Novonesis unveils its latest facility: Dairy Application & Technology Centre

DENMARK – Novonesis, a global biosolutions company, has opened its Dairy Application & Technology Centre (ATC) in Hørsholm, Denmark, to cater for consumer demands.

According to the company, the facility will empower dairy producers globally by accelerating innovation and delivering tailored solutions that address modern industry challenges.

“The ATC also opens up new opportunities for producers, whether looking to explore yield and recipe optimisation, better cheese functionality, or improve whey quality, and beyond. The ATC elevates capabilities across the board, so producers get more support for developing healthy and nutritious dairy that people love, the company said.

Additionally, the Dairy ATC can mimic numerous recipes and different types of fresh dairy products and cheeses, helping dairy producers test our biosolutions and bring their new products to the market more quickly. 

The facility is also equipped to address emerging trends, such as the growing demand for high-protein dairy products, by including a new high-protein yoghurt line.

Beyond creating innovative products, the co-creation capabilities of the Dairy ATC will help the company’s partners achieve cost efficiency, productivity gains, and get the most from their inputs.

“Cheesemakers, for example, can use the facility to test how biosolutions enhance taste, texture, shelf life, and yield – all while optimising their processes to create higher impact together,” the company noted.

Novonesis reports 11% organic growth in Q1 2025

Recently, the company reported organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The sales growth was broad-based across both regions and industries.

Emerging markets grew by 15% organically, and developed markets increased by 9%. Across all sales areas, the company delivered double-digit growth in the quarter.

Organic growth rates by geography were 14% in Europe, the Middle East & Africa, 7% in North America, 9% in Asia Pacific, and 18% in Latin America. 

Food & Beverages grew by 11% with double-digit growth across most categories. In Human Health, organic sales growth was 13%, driven by a strong development in Dietary Supplements.

Outlook 2025

The company stated that the outlook is maintained at 5-8% organic sales growth (6-9% excluding the exit from certain countries) and an adjusted EBITDA margin between 37-38% despite current currency headwinds.

Subscribe to receive our email newsletters with the latest news and insights from Africa, Middle East and around the world. SUBSCRIBE HERE